SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-001222
Filing Date
2023-01-18
Accepted
2023-01-18 16:05:16
Documents
15
Period of Report
2023-01-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20230117_8k.htm   iXBRL 8-K 37846
2 EXHIBIT 3.1 ex_464793.htm EX-3.1 7073
7 image01.jpg GRAPHIC 9942
  Complete submission text file 0001437749-23-001222.txt   197820

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arav-20230113.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20230113_def.xml EX-101.DEF 11916
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20230113_lab.xml EX-101.LAB 15956
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20230113_pre.xml EX-101.PRE 12127
9 EXTRACTED XBRL INSTANCE DOCUMENT arav20230117_8k_htm.xml XML 2644
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 23534450
SIC: 2834 Pharmaceutical Preparations